You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
利民股份(002734.SZ):控股子公司擬投建年產5000噸草銨膦項目
格隆匯 06-28 16:55

格隆匯6月28日丨利民股份(002734.SZ)公佈,公司控股子公司河北威遠生物化工有限公司(“威遠生化”)因業務發展需要,擬投資建設年產5000噸草銨膦建設項目。項目總投資額預計為45045.72萬元,建設週期預計為2年。

建設規模及內容:建設年產5000噸草銨膦生產線,新建膦酸酯工房、合成工房、原藥工房、動力車間、DCS機櫃室、導熱油路房、成品庫、液體儲罐區、循環水泵房、生活污水池、生產辦公及微型消防站、控制中心;並對3個現有液體儲罐區進行利舊改造以及項目其他配套輔助設施建設。項目建成後將形成年產4000草銨膦原藥10000草銨膦水劑的生產能力

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account